Skip to main content
Livermore
Livermore
ZHEN

BCS Wealth Management

SEC CIK
0001798172
Latest filing
Jul 16, 2026

ABT holding history

Abbott Laboratories in every 13F filed by BCS Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ABT by BCS Wealth Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−3,060−100.0%Sold outHolders
Q4 20253,060$383.4K<0.1%+3,060NewHolders
Q3 20250$00.0%−5,835−100.0%Sold outHolders
Q2 20255,835$794.0K0.2%+353+6.4%AddedHolders
Q1 20255,482$727.0K0.2%−79−1.4%ReducedHolders
Q4 20245,561$629.0K0.2%−115−2.0%ReducedHolders
Q3 20245,676$647.0K0.3%−73−1.3%ReducedHolders
Q2 20245,749$597.0K0.3%−224−3.8%ReducedHolders
Q1 20245,973$679.0K0.2%+456+8.3%AddedHolders
Q4 20235,517$607.0K0.2%00.0%UnchangedHolders
Q3 20235,517$534.0K0.2%+5,517NewHolders
Q2 20230$00.0%−2,968−100.0%Sold outHolders
Q1 20232,968$301.0K0.1%−2,701−47.6%ReducedHolders
Q4 20225,669$622.0K0.3%00.0%UnchangedHolders
Q3 20225,669$549.0K0.3%−160−2.7%ReducedHolders
Q2 20225,829$633.0K0.3%−332−5.4%ReducedHolders
Q1 20226,161$729.0K0.3%−168−2.7%ReducedHolders
Q4 20216,329$891.0K0.3%+132+2.1%AddedHolders
Q3 20216,197$732.0K0.3%00.0%UnchangedHolders
Q2 20216,197$718.0K0.4%00.0%UnchangedHolders
Q1 20216,197$743.0K0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.